{"id":61775,"date":"2025-08-27T01:06:06","date_gmt":"2025-08-26T23:06:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/"},"modified":"2025-08-27T01:06:06","modified_gmt":"2025-08-26T23:06:06","slug":"i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/","title":{"rendered":"I2Pure and Caracal Announce Expanded Collaboration and Go-To-Market Effort for Novel Iodine Products"},"content":{"rendered":"
\n

ASHBURN, Va.–(BUSINESS WIRE)–I2Pure and Caracal Products & Services, through its Caracal Healthcare Products division, today announce an expansion of their relationship. I2Pure\u2019s proprietary iodine formulations and product concepts have received an overwhelmingly favorable response from Caracal\u2019s healthcare customer base. Based on that positive feedback, I2Pure and Caracal have committed joint efforts to accelerate manufacturing and product delivery.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThree offerings make up the initial product entry: a topical iodine soak, a nasal decolonization product, and a topical iodine skin ointment. Additional products in development include surgical scrub, hand sanitizer, and several other topical iodine products.<\/p>\n

\n\u201cSince announcing our collaboration last year, Caracal has been amazed by the appetite of our healthcare customers for novel iodine products. The healthcare community clearly values the antimicrobial capability of iodine, as well as its long history of biosafety and biocompatibility,\u201d said Don Roberts, CEO of Caracal Products & Services. \u201cIn a very short time, I2Pure\u2019s technologies and products have become a primary interest within our healthcare customer base. We\u2019re excited to begin marketing and delivering I2Pure products later this year.\u201d<\/p>\n

\n\u201cA lot of hard work by our incredible team has put I2Pure in position to begin making our vision a reality. We\u2019re thrilled to be in production now to start delivering products through Caracal later this year,\u201d said Jeff Jochims, I2Pure CEO. \u201cThe world is ready for the next iteration of iodine chemistry. With ever-increasing antibiotic resistance and global pathogen risk, the time is right to harness the incredible antimicrobial broad-spectrum efficacy of molecular iodine, which has a time-proven safety profile and no known resistance development.\u201d<\/p>\n

\nI2Pure\u2019s products will be available to most healthcare customers exclusively through Caracal Products & Services. Product samples will be available in September. Product delivery is expected to begin in the fourth quarter of 2025 and to expand throughout 2026.<\/p>\n

\nCaracal and I2Pure expect to begin marketing products at healthcare conferences later this year, including the American Association of Hip and Knee Surgeons annual meeting in October and the National Minority Supplier Development Council\u2019s Annual Conference & Exchange in early November in Miami.<\/p>\n

\nAbout Caracal Products & Services<\/b>:<\/b> Founded in Detroit, Michigan, in 2004, Caracal is a U.S. based company with a focus on creating jobs and value in the healthcare industry through pioneering products and innovative services. As a sourcing solutions provider, Caracal offers a wide range of high-quality products and value-added services to businesses, government agencies, and educational institutions of all sizes. Caracal has cultivated strong, established partnerships in the healthcare, insurance, and financial services industries. Known for its proactive communication and stable, strategic vendor relationships, Caracal prides itself on living up to the Caracal motto each day: Supplying everything but surprises. For more information about Caracal Products & Services please visit https:\/\/www.caracalcorp.com<\/a> or contact Sarah Herschelman at sherschelman@caracalcorp.com<\/a>.<\/p>\n

\nAbout I2Pure:<\/b> I2Pure is an iodine technology company dedicated to advancing health and biosafety through its patented, non-toxic molecular iodine solutions. I2Pure\u2019s mission is to prevent pathogenic threats to the world. Our technology can be utilized for countless applications across healthcare, industrial biosafety, consumer products, and food processing. The platform technology can be delivered directly or through carriers via solutions, nano particles, polymers and coatings. For more information about I2Pure, visit https:\/\/www.i2pure.com<\/a> or contact the company at info@i2pure.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\ninfo@i2pure.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

ASHBURN, Va.–(BUSINESS WIRE)–I2Pure and Caracal Products & Services, through its Caracal Healthcare Products division, today announce an expansion of their relationship. I2Pure\u2019s proprietary iodine formulations and product concepts have received an overwhelmingly favorable response from Caracal\u2019s healthcare customer base. Based on that positive feedback, I2Pure and Caracal have committed joint efforts to accelerate manufacturing and … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61775","6":"format-standard","7":"category-industry"},"yoast_head":"\nI2Pure and Caracal Announce Expanded Collaboration and Go-To-Market Effort for Novel Iodine Products - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"I2Pure and Caracal Announce Expanded Collaboration and Go-To-Market Effort for Novel Iodine Products - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ASHBURN, Va.–(BUSINESS WIRE)–I2Pure and Caracal Products & Services, through its Caracal Healthcare Products division, today announce an expansion of their relationship. I2Pure\u2019s proprietary iodine formulations and product concepts have received an overwhelmingly favorable response from Caracal\u2019s healthcare customer base. Based on that positive feedback, I2Pure and Caracal have committed joint efforts to accelerate manufacturing and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-26T23:06:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250826854276\/en\/2562979\/22\/I2Pure_and_Caracal_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"I2Pure and Caracal Announce Expanded Collaboration and Go-To-Market Effort for Novel Iodine Products\",\"datePublished\":\"2025-08-26T23:06:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\\\/\"},\"wordCount\":592,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250826854276\\\/en\\\/2562979\\\/22\\\/I2Pure_and_Caracal_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\\\/\",\"name\":\"I2Pure and Caracal Announce Expanded Collaboration and Go-To-Market Effort for Novel Iodine Products - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250826854276\\\/en\\\/2562979\\\/22\\\/I2Pure_and_Caracal_Logo.jpg\",\"datePublished\":\"2025-08-26T23:06:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250826854276\\\/en\\\/2562979\\\/22\\\/I2Pure_and_Caracal_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250826854276\\\/en\\\/2562979\\\/22\\\/I2Pure_and_Caracal_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"I2Pure and Caracal Announce Expanded Collaboration and Go-To-Market Effort for Novel Iodine Products\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"I2Pure and Caracal Announce Expanded Collaboration and Go-To-Market Effort for Novel Iodine Products - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/","og_locale":"en_US","og_type":"article","og_title":"I2Pure and Caracal Announce Expanded Collaboration and Go-To-Market Effort for Novel Iodine Products - Pharma Trend","og_description":"ASHBURN, Va.–(BUSINESS WIRE)–I2Pure and Caracal Products & Services, through its Caracal Healthcare Products division, today announce an expansion of their relationship. I2Pure\u2019s proprietary iodine formulations and product concepts have received an overwhelmingly favorable response from Caracal\u2019s healthcare customer base. Based on that positive feedback, I2Pure and Caracal have committed joint efforts to accelerate manufacturing and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/","og_site_name":"Pharma Trend","article_published_time":"2025-08-26T23:06:06+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250826854276\/en\/2562979\/22\/I2Pure_and_Caracal_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"I2Pure and Caracal Announce Expanded Collaboration and Go-To-Market Effort for Novel Iodine Products","datePublished":"2025-08-26T23:06:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/"},"wordCount":592,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250826854276\/en\/2562979\/22\/I2Pure_and_Caracal_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/","url":"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/","name":"I2Pure and Caracal Announce Expanded Collaboration and Go-To-Market Effort for Novel Iodine Products - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250826854276\/en\/2562979\/22\/I2Pure_and_Caracal_Logo.jpg","datePublished":"2025-08-26T23:06:06+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250826854276\/en\/2562979\/22\/I2Pure_and_Caracal_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250826854276\/en\/2562979\/22\/I2Pure_and_Caracal_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/i2pure-and-caracal-announce-expanded-collaboration-and-go-to-market-effort-for-novel-iodine-products\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"I2Pure and Caracal Announce Expanded Collaboration and Go-To-Market Effort for Novel Iodine Products"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61775","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61775"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61775\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}